Education
About Us
Working with TipRanks
Follow Us
Atlas Venture Fund IX, L.P. Insider Profile
4 Followers
Atlas Venture Fund IX, L.P., Ten Percent Owner at Intellia Therapeutics, holds 2.95M shares in Surface Oncology (Ticker: SURF), holds 3.36M shares in Cogent Biosciences (Ticker: COGT), holds 3.73M shares in Intellia Therapeutics (Ticker: NTLA). Most recently, Atlas Venture Fund IX, L.P. Sold ― shares of Surface Oncology on Dec 21, 2020 for an estimated value of 30.77M.
Atlas Venture Fund IX, L.P. Intellia Therapeutics (NTLA)Ten Percent Owner
Intellia Therapeutics (NTLA)
Ten Percent Owner
Ranked #75,112 out of 78,905 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-73.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Atlas Venture Fund IX, L.P. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Atlas Venture Fund IX, L.P.
Atlas Venture Fund IX, L.P.'s Trading History
Intellia Therapeutics
Jul 11, 2017
Ten Percent Owner
Informative Sell
2.43M
$236.95M
Cogent Biosciences
Apr 03, 2018
Ten Percent Owner
Uninformative Buy
―
$41.01M
Surface Oncology
Dec 21, 2020
Ten Percent Owner
Informative Sell
30.77M
$29.81M
List of latest transactions for each holding click on a transaction to see Atlas Venture Fund IX, L.P.'s performance on stock
You May Also Like
Atlas Venture Fund IX, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Atlas Venture Fund IX, L.P.?
The percentage of profitable transactions made by Atlas Venture Fund IX, L.P. is 0%.
What is the average return per transaction made by Atlas Venture Fund IX, L.P.?
The average return per transaction made by Atlas Venture Fund IX, L.P. is -73.90%.
What stocks does Atlas Venture Fund IX, L.P. hold?
Atlas Venture Fund IX, L.P. holds: NTLA, COGT, SURF stocks.
What was Atlas Venture Fund IX, L.P.’s latest transaction?
Atlas Venture Fund IX, L.P. latest transaction was an Informative Sell of $30.77M.
What was Atlas Venture Fund IX, L.P.'s most profitable transaction?
Atlas Venture Fund IX, L.P.’s most profitable transaction was an Informative Buy of COGT stock on April 3, 2018. The return on the trade was -59.30%.
What is Atlas Venture Fund IX, L.P.'s role in Intellia Therapeutics?
Atlas Venture Fund IX, L.P.'s role in Intellia Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.